BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9894743)

  • 1. The role of platelet-activating factor in the haemoincompatibility of haemodialytic treatments.
    Tetta C; Wratten M; Cristol JP; Tarchini R; Bosc JY; Canaud B; Camussi G
    Int J Artif Organs; 1998 Nov; 21(11):693-8. PubMed ID: 9894743
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of platelet activating factor in hemodialysis.
    Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
    Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of platelet-activating factor in the biocompatibility of hemodialysis membranes.
    Tetta C; Haeffner-Cavaillon N; Navino C; David S; Franceschi C; Mariano F; Camussi G
    Adv Exp Med Biol; 1996; 416():243-8. PubMed ID: 9131156
    [No Abstract]   [Full Text] [Related]  

  • 4. Biocompatibility of dialysis membranes.
    Salem M; Ivanovich P; Mujais S
    Contrib Nephrol; 1993; 103():55-64. PubMed ID: 8354063
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
    Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
    Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis-related bioincompatibility and adhesion molecules.
    Dhondt A; Vanholder R; Lameire N
    Int J Artif Organs; 1998 Sep; 21(9):501-5. PubMed ID: 9828053
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of complement in biomaterial-induced inflammation.
    Nilsson B; Ekdahl KN; Mollnes TE; Lambris JD
    Mol Immunol; 2007 Jan; 44(1-3):82-94. PubMed ID: 16905192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte-derived mediators and biocompatibility.
    Tetta C; Segoloni G; Mariano F; Montrucchio G; Turello E; Camussi G
    Nephrol Dial Transplant; 1991; 6 Suppl 2():24-30. PubMed ID: 1866064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biocompatibility].
    Uematsu K; Akizawa T
    Nihon Rinsho; 2004 May; 62 Suppl 5():37-40. PubMed ID: 15197884
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis.
    Kabasakal C; Mir S; Gousseinov A; Cura A; Betin N; Coker I
    Turk J Pediatr; 1998; 40(3):413-20. PubMed ID: 9763906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence of blood cells to dialyzer membranes as a measure of biocompatibility.
    Kjellstrand P; Okmark P; Odselius R; Thysell H; Riede G; Holmquist B
    Int J Artif Organs; 1991 Nov; 14(11):698-702. PubMed ID: 1757156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodialysis-induced arterial hypoxaemia. Pathophysiology and clinical implications. A review.
    Knudsen F; Nielsen AH
    Dan Med Bull; 1984 Apr; 31(2):154-7. PubMed ID: 6426868
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the Biocompatibility of Dialysis Membranes.
    Kokubo K; Kurihara Y; Kobayashi K; Tsukao H; Kobayashi H
    Blood Purif; 2015; 40(4):293-7. PubMed ID: 26656534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone.
    Amato M; Salvadori M; Bergesio F; Messeri A; Filimberti E; Morfini M
    Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-complement interaction. A beneficial antimicrobial mechanism that can cause disease.
    Jacob HS
    Arch Intern Med; 1978 Mar; 138(3):461-3. PubMed ID: 147065
    [No Abstract]   [Full Text] [Related]  

  • 17. The production of platelet-activating factor (PAF) during hemodialysis with cuprophane membrane. Does the calcium concentration in the dialysate play any role on it?
    Iatrou C; Afentakis N; Antonopoulou S; Andrikopoulos N; Demopoulos CA; Ziroyannis P
    Int J Artif Organs; 1995 Jul; 18(7):355-61. PubMed ID: 8655220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dialysis membranes in infection.
    Vanholder R; Van Loo A; Dhondt AM; Ringoir S
    Nephrol Dial Transplant; 1996; 11 Suppl 2():101-3. PubMed ID: 8804006
    [No Abstract]   [Full Text] [Related]  

  • 19. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 20. PAF-acether and kidney pathology.
    Pirotzky E; Braquet P
    Prog Biochem Pharmacol; 1988; 22():168-80. PubMed ID: 3043431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.